Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">Concentration before experiment (mmol/L)</td><td class="align_center">Concentration after experiment (mmol/L)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Control group</td><td class="align_center">26.80 ± 11.19</td><td class="align_center">10.74 ± 10.88</td></tr><tr><td class="align_left">Experience group</td><td class="align_center">27.30 ± 10.96</td><td class="align_center">9.50 ± 12.50</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Analysis of blood bun concentration before and after the two groups.</div>

Journal of Chemistry

tab2

Table 2

Table 2: Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department 

Table 2 | Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department 